SEC Form 5 · accession 0001209191-17-003975
Insys Therapeutics, Inc. · INSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darryl S Baker
Officer — Chief Financial Officer
Period of report
Dec 31, 2016
Accepted (ET)
Jan 17, 2017 · 7:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516479
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 10, 2016 | G | 4,000 | $0.00 | D | 18,312 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,282 shares acquired by the Reporting Person on June 10, 2016 pursuant to the Issuer's Employer Stock Purchase Plan.